false000007233100000723312023-12-132023-12-13

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 13, 2023
NORDSON CORPORATION
(Exact Name of Registrant as Specified in its Charter)
Ohio000-0797734-0590250
(State or Other
Jurisdiction of Incorporation)
(Commission File Number)
(I.R.S. Employer
Identification Number)
28601 Clemens Road
WestlakeOhio 44145
(Address of Principal Executive
Offices, including Zip Code)
Registrant’s Telephone Number, including Area Code: 440-892-1580
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of Each Exchange
On Which Registered
Common Shares, without par valueNDSNNasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 



Item 2.02.    Results of Operations and Financial Condition.
On December 13, 2023, Nordson Corporation issued a press release relating to its results of operations for the fourth quarter and full fiscal year 2023.  A copy is attached as Exhibit 99.1.
Item 7.01.    Regulation FD Disclosure.
Nordson Corporation will provide additional commentary on fourth quarter and full year fiscal 2023 results and outlook during a webcast on Thursday, December 14, 2023 at 8:30 a.m. eastern time, which can be accessed at https://investors.nordson.com. For persons unable to listen to the live broadcast, a replay will be available for 14 days after the event.
As provided in General Instruction B.2 of Form 8-K, the information contained in Items 2.02 and 7.01 of this Form 8-K shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall any such information be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01    Financial Statements and Exhibits.(d) Exhibits.
(d) Exhibits.
Press release of Nordson Corporation dated December 13, 2023.
104
Cover Page Interactive Data File (embedded within the inline XBRL document).



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
NORDSON CORPORATION
Date:
December 13, 2023
By: /s/ Stephen Shamrock
Stephen Shamrock
Vice President and Corporate Controller, Interim Chief Financial Officer



Nordson Corporation Reports Fourth Quarter and Record Fiscal Year 2023 Results
Fourth Quarter:
Sales were $719 million, a 5% increase over prior year
Operating profit was $185 million
EBITDA was a quarterly record of $227 million, 32% of sales
Earnings per diluted share were $2.22
Adjusted earnings per diluted share were $2.46
Full Year:
Record sales of $2.6 billion, reflecting 2% growth over last year’s record sales
EBITDA was a record $819 million, 31% of sales
Earnings per diluted share were $8.46
Adjusted earnings per diluted share were $9.03

2024 Guidance:
Fiscal 2024 forecasted sales growth of 4% to 9% and adjusted earnings in the range of 1% to 8% growth over fiscal 2023

WESTLAKE, Ohio--(BUSINESS WIRE)--December 13, 2023--Nordson Corporation (Nasdaq: NDSN) today reported results for the fiscal fourth quarter ended October 31, 2023. Sales were $719 million, a 5% increase compared to the prior year’s fourth quarter sales of $684 million. The increase in fourth quarter 2023 sales included the favorable 7% impact of acquisitions and favorable currency translation of 1%, offset by an organic decrease of 3%. The organic sales decrease was driven by electronics dispense and biopharma product lines, offset by strong growth in medical interventional solutions, industrial coatings and polymer processing product lines.

Operating profit in the quarter was $185 million, or 26% of sales. Adjusted operating profit, excluding $11 million in non-recurring acquisition costs, totaled $196 million, or 27% of sales. This was a 10% increase compared to prior year adjusted operating profit of $178 million. EBITDA in the quarter totaled a record $227 million, or 32% of sales, and represents an increase of 12% from the prior year EBITDA of $202 million.
Net income was $128 million, or earnings per diluted share of $2.22. Adjusted net income was $142 million, excluding $7 million of non-recurring financing costs related to the ARAG acquisition. Fourth quarter 2023 adjusted earnings per diluted share were $2.46 compared to prior year adjusted earnings per diluted share of $2.44. The increase was driven by higher sales, offset by higher interest expense.
Commenting on the Company’s fiscal 2023 fourth quarter results, Nordson President and Chief Executive Officer Sundaram Nagarajan said, “The diversification of Nordson’s precision technology portfolio and the progress of the Ascend strategy shined through again this quarter. Our medical interventional solutions and several industrial precision product lines delivered double-digit growth in the quarter, while demand weakness in electronics and biopharma end markets persisted as expected. Throughout this dynamic year, our winning teams have remained focused on meeting the needs of our customers. They demonstrated an owner mindset and responded rapidly over the course of the year to changing market conditions. This led to total company performance exceeding our incremental profit targets. I am also very pleased with the integration progress of our recent ARAG acquisition, which contributed favorably to the fourth quarter results.”
Fourth Quarter Segment Results
Industrial Precision Solutions sales of $405 million increased 14% compared to the prior year fourth quarter, driven by a 4% organic sales increase, a favorable acquisition impact of 7%, and a favorable currency impact of 2%. The organic sales increase was driven by record sales in our packaging, industrial coating and polymer processing product lines, largely driven by strong system sales in the Americas and Asia Pacific. Adjusted operating profit, which excludes non-recurring charges related to the ARAG acquisition, totaled $136 million in the quarter, or 34% of sales, an increase of 23% compared to the prior year operating profit. The increase in operating profit was driven by higher sales and improved sales mix.

1


Medical and Fluid Solutions sales of $169 million decreased 7% compared to the prior year fourth quarter, driven by an organic sales decrease of 8% that was partially offset by a favorable currency impact of 1%. The organic sales decrease was driven by continued softness in medical fluid components and fluid solutions product lines, partially offset by double-digit growth in our medical interventional solutions product lines. Operating profit totaled $48 million in the quarter, or 28% of sales, a decrease of 7% compared to the prior year operating profit due to lower sales volumes.

Advanced Technology Solutions sales of $145 million decreased 1% compared to the prior year fourth quarter, driven by an organic sales decrease of 16% that was principally offset by a favorable acquisition impact of 15% and a favorable currency impact of 1%. The organic sales decline was primarily driven by continued softness in our electronic dispense product lines, which serves the cyclical semiconductor end markets. Operating profit totaled $32 million in the quarter, or 22% of sales, a decrease of 16% compared to the prior year operating profit due to lower organic sales volume.

Fiscal 2023 Full Year Results
Sales for the fiscal year ended October 31, 2023, were a record $2.6 billion, an increase of 2% compared to the prior year. This sales growth was driven by a favorable acquisition impact of 4%, partially offset by a 1% decrease in organic volume and an unfavorable currency impact of 1%. Full year operating profit was $673 million. Net income was $487 million and diluted earnings per share were $8.46.
Adjusted operating profit, excluding $34 million in non-recurring costs, was $707 million, or 27% of sales, comparable to prior year adjusted operating profit of $707 million. EBITDA totaled a record $819 million, or 31% of sales. Adjusted diluted earnings per share were $9.03, a 4% decrease from the prior year earnings per diluted share of $9.43, primarily due to higher interest expense.
Reflecting on fiscal 2023, Mr. Nagarajan continued, “In 2021, we launched our Ascend strategy with the milestone of achieving $3 billion in annual sales and greater than 30% EBITDA margins by 2025. As we complete the third year of our strategy, we are on track toward achieving this objective. This is our third consecutive year of record sales, demonstrating the execution of the NBS Next growth framework, exciting acquisitions reflecting our strategic capital deployment, entrepreneurial owner mindset and the continued development of winning teams at every level of our organization. In fiscal 2024, we are well positioned for the recovery of select end markets and the related incremental earnings power that will come with that growth. The Ascend strategy is creating a scalable, high quality earnings growth engine. I want to thank Nordson’s employees and customers for all of their continued support.”
Outlook
Following three consecutive years of record setting performance and a strong finish to fiscal 2023, we enter fiscal 2024 with approximately $800 million in backlog. The book-to-bill in the fourth quarter and the majority of 2023 was unfavorable as over $200 million in backlog was consumed.
Based on the combination of order entry, backlog and current exchange rates, we anticipate delivering sales growth in the range of 4% to 9% in fiscal 2024 when compared to fiscal 2023. Full year fiscal 2024 adjusted earnings are forecasted in the range of 1% to 8% growth per diluted share.
First quarter fiscal 2024 sales are forecasted in the range of $615 to $640 million with adjusted earnings in the range of $2.00 to $2.10 per diluted share. Starting in fiscal 2024, the Company’s definition of adjusted earnings will exclude acquisition related amortization for both current and historical periods (see the appendix for historical amounts).
Nordson management will provide additional commentary on these results and outlook during its previously announced webcast on Thursday, December 14, 2023 at 8:30 a.m. eastern time, which can be accessed at https://investors.nordson.com. For persons unable to listen to the live broadcast, a replay will be available for 14 days after the event. Information about Nordson’s investor relations and shareholder services is available from Lara Mahoney, vice president, investor relations and corporate communications at (440) 204-9985 or lara.mahoney@nordson.com.

Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by terminology such as “may,” “will,” “should,” “could,” “expects,” “anticipates,” “believes,” “projects,” “forecasts,” “outlook,” “guidance,” “continue,” “target,” or the negative of these terms or comparable terminology. These statements reflect management’s current expectations and involve a number of risks and uncertainties. These risks and uncertainties include, but are not limited to, U.S. and international economic conditions; financial and market conditions; currency exchange rates and devaluations; possible acquisitions, including the
2


Company’s ability to successfully integrate acquisitions; the Company’s ability to successfully divest or dispose of businesses that are deemed not to fit with its strategic plan; the effects of changes in U.S. trade policy and trade agreements; the effects of changes in tax law; and the possible effects of events beyond our control, such as political unrest, including conflicts in Europe and the Middle East, acts of terror, natural disasters and pandemics, including the recent coronavirus (COVID-19) pandemic and the other factors discussed in Item 1A (Risk Factors) in the Company’s most recently filed Annual Report on Form 10-K and in its Forms 10-Q filed with the Securities and Exchange Commission, which should be reviewed carefully. The Company undertakes no obligation to update or revise any forward-looking statement in this press release.

Nordson Corporation is an innovative precision technology company that leverages a scalable growth framework through an entrepreneurial, division-led organization to deliver top tier growth with leading margins and returns. The Company’s direct sales model and applications expertise serves global customers through a wide variety of critical applications. Its diverse end market exposure includes consumer non-durable, medical, electronics and industrial end markets. Founded in 1954 and headquartered in Westlake, Ohio, the Company has operations and support offices in over 35 countries. Visit Nordson on the web at www.nordson.com, www.twitter.com/Nordson_Corp or www.facebook.com/nordson.
3


NORDSON CORPORATION
CONSOLIDATED STATEMENT OF INCOME (Unaudited)
(Dollars in thousands except for per-share amounts)
Three Months EndedTwelve Months Ended
October 31, 2023October 31, 2022October 31, 2023October 31, 2022
Sales$719,313 $683,581 $2,628,632 $2,590,278 
Cost of sales335,220 320,398 1,203,227 1,163,742 
Gross profit384,093 363,183 1,425,405 1,426,536 
Gross margin %53.4 %53.1 %54.2 %55.1 %
Selling & administrative expenses199,054 185,574 752,644 724,176 
Operating profit185,039 177,609 672,761 702,360 
Interest expense - net(25,921)(5,095)(56,825)(20,387)
Other income (expense) - net1,462 5,026 (597)(32,694)
Income before income taxes160,580 177,540 615,339 649,279 
Income taxes32,802 36,291 127,846 136,176 
Net Income$127,778 $141,249 $487,493 $513,103 
Weighted-average common shares outstanding:
Basic57,020 57,170 57,090 57,629 
Diluted57,552 57,823 57,631 58,249 
Earnings per share:
Basic earnings$2.24 $2.47 $8.54 $8.90 
Diluted earnings$2.22 $2.44 $8.46 $8.81 
4


NORDSON CORPORATION
CONSOLIDATED BALANCE SHEET (Unaudited)
(Dollars in thousands)
October 31, 2023October 31, 2022
Cash and cash equivalents$115,679 $163,457 
Receivables - net590,886 537,313 
Inventories - net454,775 383,398 
Other current assets67,970 48,803 
Total current assets1,229,310  1,132,971 
Property, plant & equipment - net392,846 353,442 
Goodwill2,784,201 1,804,693 
Other assets845,413 529,269 
$5,251,770 $3,820,375 
Notes payable and debt due within one year$115,662 $392,537 
Accounts payable and accrued liabilities466,427 441,666 
Total current liabilities582,089 834,203 
Long-term debt1,621,394 345,320 
Other liabilities450,227 346,477 
Total shareholders' equity2,598,060 2,294,375 
$5,251,770 $3,820,375 

5


NORDSON CORPORATION
CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)
(Dollars in thousands)
Twelve Months Ended
October 31, 2023October 31, 2022
Cash flows from operating activities:
Net Income$487,493 $513,103 
Depreciation and amortization111,898 99,923 
Other non-cash items16,105 63,174 
Changes in working capital    (3,571)(107,314)
Other29,357 (55,755)
Net cash provided by operating activities    641,282 513,131 
Cash flows from investing activities:
Additions to property, plant and equipment(34,583)(51,428)
Acquisitions    (1,422,780)(171,613)
Other - net20,484 280 
Net cash used in investing activities(1,436,879)(222,761)
Cash flows from financing activities:
Borrowing (repayment) of long-term debt976,043 (33,908)
Repayment of finance lease obligations(6,840)(5,439)
Dividends paid(150,356)(125,914)
Issuance of common shares21,373 12,124 
Purchase of treasury shares(89,708)(262,869)
Net cash used in financing activities750,512 (416,006)
Effect of exchange rate change on cash(2,693)(10,879)
Net change in cash and cash equivalents(47,778)(136,515)
Cash and cash equivalents:
Beginning of period163,457 299,972 
End of period$115,679 $163,457 
6


NORDSON CORPORATION
SALES BY GEOGRAPHIC SEGMENT (Unaudited)
(Dollars in thousands)
Three Months EndedSales Variance
October 31, 2023October 31, 2022OrganicAcquisitionsCurrencyTotal
SALES BY SEGMENT
Industrial precision solutions$405,436 $355,659 4.4 %7.2 %2.4 %14.0 %
Medical and fluid solutions168,632 181,342 (7.6)%— %0.6 %(7.0)%
Advanced technology solutions145,245 146,580 (16.4)%15.0 %0.5 %(0.9)%
Total sales$719,313 $683,581 (3.1)%6.9 %1.4 %5.2 %
SALES BY GEOGRAPHIC REGION
Americas315,635 303,738 (0.9)%4.0 %0.8 %3.9 %
Europe184,297 165,702 (6.3)%12.0 %5.5 %11.2 %
Asia Pacific219,381 214,141 (3.8)%7.2 %(1.0)%2.4 %
Total sales$719,313 $683,581 (3.1)%6.9 %1.4 %5.2 %
Twelve Months EndedSales Variance
October 31, 2023October 31, 2022OrganicAcquisitionsCurrencyTotal
SALES BY SEGMENT
Industrial precision solutions$1,391,046 $1,337,242 3.1 %1.9 %(1.0)%4.0 %
Medical and fluid solutions660,316 690,177 (3.7)%— %(0.6)%(4.3)%
Advanced technology solutions577,270 562,859 (9.2)%12.9 %(1.1)%2.6 %
Total sales$2,628,632 $2,590,278 (1.4)%3.8 %(0.9)%1.5 %
SALES BY GEOGRAPHIC REGION
Americas1,149,760 1,096,596 2.0 %2.4 %0.4 %4.8 %
Europe682,676 645,603 1.4 %4.2 %0.1 %5.7 %
Asia Pacific796,196 848,079 (8.2)%5.2 %(3.1)%(6.1)%
Total sales$2,628,632 $2,590,278 (1.4)%3.8 %(0.9)%1.5 %
7


NORDSON CORPORATION
RECONCILIATION OF NON-GAAP MEASURES - ADJUSTED OPERATING PROFIT AND EBITDA (Unaudited)
(Dollars in thousands)
Three Months EndedTwelve Months Ended
October 31, 2023October 31, 2022October 31, 2023October 31, 2022
SALES BY SEGMENT
Industrial precision solutions$405,436 $355,659 $1,391,046 $1,337,242 
Medical and fluid solutions168,632 181,342 660,316 690,177 
Advanced technology solutions145,245 146,580 577,270 562,859 
Total sales$719,313 $683,581 $2,628,632 $2,590,278 
OPERATING PROFIT
Industrial precision solutions$131,450 $110,387 $460,889 $434,476 
Medical and fluid solutions48,041 51,689 189,367 217,199 
Advanced technology solutions31,526 37,720 101,662 133,253 
Corporate(25,978)(22,187)(79,157)(82,568)
Total operating profit$185,039 $177,609 $672,761 $702,360 
OPERATING PROFIT ADJUSTMENTS (1)
Industrial precision solutions$4,658 $— $4,658 $1,563 
Medical and fluid solutions— — 1,479 2,498 
Advanced technology solutions— — 14,304 — 
Corporate6,142 — 13,874 897 
Total adjustments$10,800 $— $34,315 $4,958 
ADJUSTED OPERATING PROFIT (NON-GAAP)% of Sales% of Sales% of Sales% of Sales
Industrial precision solutions$136,108 34 %$110,387 31 %$465,547 33 %$436,039 33 %
Medical and fluid solutions48,041 28 %51,689 29 %190,846 29 %219,697 32 %
Advanced technology solutions31,526 22 %37,720 26 %115,966 20 %133,253 24 %
Corporate(19,836)(22,187)(65,283)(81,671)
Total operating profit - adjusted$195,839 27 %$177,609 26 %$707,076 27 %$707,318 27 %
DEPRECIATION & AMORTIZATION
Industrial precision solutions$12,062 $7,186 $33,228 $27,891 
Medical and fluid solutions13,547 12,528 54,988 54,674 
Advanced technology solutions3,529 2,075 15,185 8,780 
Corporate2,123 2,892 8,497 8,578 
Total depreciation & amortization$31,261 $24,681 $111,898 $99,923 
EBITDA (NON-GAAP) (2)
Industrial precision solutions$148,170 37 %$117,573 33 %$498,775 36 %$463,930 35 %
Medical and fluid solutions61,588 37 %64,217 35 %245,834 37 %274,371 40 %
Advanced technology solutions35,055 24 %39,795 27 %131,151 23 %142,033 25 %
Corporate(17,713)(19,295)(56,786)(73,093)
Total EBITDA$227,100 32 %$202,290 30 %$818,974 31 %$807,241 31 %
(1) Represents severance, as well as fees and non-cash inventory charges associated with acquisitions.
(2) Adjusted operating profit and EBITDA are non-GAAP measures used by management to evaluate the Company's ongoing operations. Adjusted operating profit is defined as operating profit plus certain adjustments, such as severance, fees and non-
8


cash inventory charges associated with acquisitions. EBITDA is defined as adjusted operating profit plus depreciation and amortization.
NORDSON CORPORATION
RECONCILIATION OF NON-GAAP MEASURES - PROFITABILITY (Unaudited)
(Dollars in thousands)
Three Months EndedTwelve Months Ended
October 31, 2023October 31, 2022October 31, 2023October 31, 2022
GAAP AS REPORTED
Operating profit$185,039 $177,609 $672,761 $702,360 
Other / interest expense - net(24,459)(69)(57,422)(53,081)
Net income127,778 141,249 487,493 513,103 
Diluted earnings per share$2.22 $2.44 $8.46 $8.81 
Shares outstanding - diluted57,552 57,823 57,631 58,249 
OPERATING PROFIT ADJUSTMENTS
Inventory step-up amortization$4,556 $— $8,862 $1,563 
Severance and other — — 5,487 3,395 
Acquisition costs6,244 — 19,966 — 
NON-OPERATING EXPENSE ADJUSTMENTS
Pension settlement loss$— $— $— $41,221 
Interest6,817 — 6,817 — 
Total adjustments$17,617 $— $41,132 $46,179 
Adjustments net of tax$14,019 $— $32,641 $36,355 
EPS effect of adjustments and other discrete tax items$0.24 $— $0.57 $0.62 
NON-GAAP MEASURES-ADJUSTED PROFITABILITY
Operating profit (1)
$195,839 $177,609 $707,076 $707,318 
Operating profit % of sales27.2 %26.0 %26.9 %27.3 %
Net income (2)
$141,797 $141,249 $520,134 $549,458 
Diluted earnings per share (3)
$2.46 $2.44 $9.03 $9.43 

(1) Adjusted operating profit is defined as operating profit plus certain adjustments, such as severance, fees and non-cash inventory charges related to acquisitions. Adjusted operating profit as a percentage of sales is defined as adjusted operating profit divided by sales.
(2) Adjusted net income is defined as net income plus tax effected adjustments and other discrete tax items.
(3) Adjusted earnings per share is defined as GAAP EPS adjusted for tax effected adjustments and other discrete tax items.

Management uses these non-GAAP measures internally to make strategic decisions, forecast future results, and evaluate the Company's current performance. Given management's use of these non-GAAP measures, the Company believes these measures are important to investors in understanding the Company's current and future operating results as seen through the eyes of management. In addition, management believes these non-GAAP measures are useful to investors in enabling them to better assess changes in the Company's core business across different time periods. Because non-GAAP financial measures are not standardized, it may not be possible to compare these financial measures to other companies' non-GAAP financial measures, even if they have similar names. Amounts may not add due to rounding.
9


NORDSON CORPORATION
APPENDIX - RECONCILIATION OF NON-GAAP MEASURES - PROFITABILITY (Unaudited)
(Dollars in thousands)

Three Months EndedTwelve Months Ended
October 31, 2023July 31, 2023April 30, 2023January 31, 2023October 31, 2023
GAAP net income as reported$127,778 $127,891 $127,563 $104,261 $487,493 
Diluted earnings per share$2.22 $2.22 $2.21 $1.81 $8.46 
Operating and non-operating adjustments$17,617 $9,781 $3,439 $10,295 $41,132 
Adjustments net of tax$14,019 $7,719 $2,714 $8,189 $32,641 
EPS effect of non-recurring adjustments$0.24 $0.13 $0.05 $0.14 $0.57 
Adjusted EPS (as previously reported)$2.46 $2.35 $2.26 $1.95 $9.03 
Acquisition amortization of intangibles $17,881 $13,922 $14,044 $13,872 $59,719 
Acquisition amortization net of tax$14,228 $10,987 $11,084 $11,034 $47,333 
EPS effect of acquisition amortization$0.25 $0.19 $0.19 $0.19 $0.82 
Revised adjusted EPS$2.71 $2.54 $2.45 $2.14 $9.85 

Three Months EndedTwelve Months Ended
October 31, 2022July 31, 2022April 30, 2022January 31, 2022October 31, 2022
GAAP net income as reported$141,249 $141,811 $109,634 $120,409 $513,103 
Diluted earnings per share$2.44 $2.45 $1.88 $2.05 $8.81 
Operating and non-operating adjustments$— $3,395 $41,221 $1,563 $46,179 
Adjustments net of tax$— $2,667 $32,450 $1,238 $36,355 
EPS effect of non-recurring adjustments$— $0.04 $0.56 $0.02 $0.62 
Adjusted EPS (as previously reported)$2.44 $2.49 $2.43 $2.07 $9.43 
Acquisition amortization of intangibles $12,459 $12,766 $12,753 $12,847 $50,825 
Acquisition amortization net of tax$9,911 $10,029 $10,039 $10,179 $40,158 
EPS effect of acquisition amortization$0.17 $0.17 $0.17 $0.17 $0.68 
Revised adjusted EPS$2.61 $2.67 $2.61 $2.24 $10.13 


Contact

Lara Mahoney
Vice President,
Investor Relations & Corporate Communications
440.204.9985
Lara.Mahoney@nordson.com
10
v3.23.3
Cover
Dec. 13, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Dec. 13, 2023
Entity Registrant Name NORDSON CORPORATION
Amendment Flag false
Entity Central Index Key 0000072331
Entity Incorporation, State or Country Code OH
Entity File Number 000-07977
Entity Tax Identification Number 34-0590250
Entity Address, Address Line One 28601 Clemens Road
Entity Address, City or Town Westlake
Entity Address, State or Province OH
Entity Address, Postal Zip Code 44145
City Area Code 440
Local Phone Number 892-1580
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Shares, without par value
Trading Symbol NDSN
Security Exchange Name NASDAQ
Entity Emerging Growth Company false

Nordson (NASDAQ:NDSN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Nordson Charts.
Nordson (NASDAQ:NDSN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Nordson Charts.